Journals / Hacettepe Sağlık İdaresi Dergisi / 2013 / Cilt: 16 - Sayı: 2

-

Sağlık Hizmetlerinde Maliyet Etkililik Analizi ve Karar Analizi

Pages
121–134
Publication Date
2013-04-01
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In this article, economical evaluation techniques, cost effectiveness analysis process, discounting, sensitivity analysis, budget impact analysis and decision analysis are discussed.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Cost effectiveness as well as medical efficiency, security and quality criteria is taken into consideration in repayment decisions in today’s health care environment..
📊
Key Findings & Data:Therefore, those who produce health technology should also provide evidence regarding whether the product is worth the money spent or not in order to be able to find a place for themselves in the market and to be included in the repayment cover.
💡
Conclusion & Impact:In this article, economical evaluation techniques, cost effectiveness analysis process, discounting, sensitivity analysis, budget impact analysis and decision analysis are discussed.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Ekonomik değerlendirme · Maliyet-etkililik · Karar analizi

Abstract

Cost effectiveness as well as medical efficiency, security and quality criteria is taken into consideration in repayment decisions in today’s health care environment.. Therefore, those who produce health technology should also provide evidence regarding whether the product is worth the money spent or not in order to be able to find a place for themselves in the market and to be included in the repayment cover. Cost effectiveness analysis is both an inclusive concept used for all the economical evaluation techniques and one of the economical evaluation techniques. In this article, economical evaluation techniques, cost effectiveness analysis process, discounting, sensitivity analysis, budget impact analysis and decision analysis are discussed.

Özet

Günümüzde geri ödeme kararlarında tıbbi etkililik, güvenlik, kalite kriterleri ile birlikte maliyet etkililik de göz önünde tutulmaktadır. Bu nedenle sağlık teknolojisi üretenlerin piyasa içinde yer bulabilmeleri ve geri ödeme kapsamına alınabilmeleri için ürünün harcanan paraya değer olup olmadığını gösteren maliyet etkililik konusunda da kanıt sağlamaları gerekmektedir. Maliyet etkililik analizi, hem ekonomik değerlendirme tekniklerinin tamamı için kullanılan kapsayıcı bir kavram olmakla birlikte, hem de ekonomik değerlendirme tekniklerinden bir tanesidir. Bu makalede, ekonomik değerlendirme teknikleri, maliyet etkililik analiz süreci, indirgeme, duyarlılık analizi, bütçe etki analiz ve karar analizi ele alınmaktadır.

🔖

Cite This Article

BALÇIK, P. Y., ŞAHİN, B. (2013). -. Hacettepe Sağlık İdaresi Dergisi, Cilt: 16 - Sayı: 2, 121–134. https://ajindex.com/articles/669810

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (9)

  1. Alp S. (Mayıs 2007) Türkiye’de Eğitim Sürecinin Markov Geçiş Modeli [Bildiri]. 8. Türkiye Ekonometri ve İstatistik Kongresi. Malatya. Berger M.L. Bingefors K. Hedblom, E.C. and Pashos C.L. (2003)
  2. Health Care Cost, Quality, and Outcomes. ISPOR Book of Terms. USA: ISPOR. Briggs A. and Sculpher M. (1998) An Introduction to Markov Modelling for Economic Evaluation. Pharmaco Economics. 13(4): 397-409.
  3. Creese A. and Parker D. (1998) Birinci Basamak Sağlık Hizmetlerinde Maliyet Analizi. Program Yöneticileri için Eğitim El Kitabı (M. Tatar ve F. Tatar Çev.). Ankara: T.C. Sağlık Bakanlığı Sağlık Projesi Genel Koordinatörlüğü. (1994).
  4. Çelik Y. (2011) Sağlık Ekonomisi. Ankara: Siyasal Kitapevi. Drummond M.F. Sculpher M.J. Torrance G.W. O’Brien B.J. and Stoddart G.L. (2005) Methods for the Economic Evaluation of Health Care Programmes (Third Edition). New York: Oxford University Press. Drummond M.F. Aguiar-Ibanez R. and Nixon J. (2006) Economic Evaluation. Singapore Medical Journal, 47(6): 456-462.
  5. Earle C. Coyle D. and Evans W.K. (1998) Cost Effectiveness Analysis in Oncology. Annals of Oncology, 9:475-482. Edejer T.T. Baltussen R. Adam T. Hutubessy R. Acharya A. Evans E.B. et al. (2003) Making Choices in Health: WHO Guide to Cost-Effectiveness Analysis. Geneva: WHO. Gold M.R. Siegel J.A. Russell L.B. and Weinstein M.C. (1996) Cost-Effectiveness in Health and Medicine. New York: Oxford University Press.
  6. Goodacre S. and McCabe C. (2002) An Introduction to Economic Evaluation. Emergency Medicine Journal, 19: 198–201. Haddix A.C. Corso P.S. and Gorsky R.D. (2003)
  7. Cost. A.C. Haddix, S.M. Teutsch, ve P.S. Corso (Ed.). A Guide to Decision Analysis and Economic Evaluation. USA: Oxford University Press.
  8. Hartz S. and John J. (2007) Public Health Policy Decisions on Medical Innovations: What Role Can Early Economic Evaluation Play?. Jena Economic Research Paper, (2007-095).
  9. Kavanos P. ve Tatar M. (2007) Sağlık Teknolojisi Değerlendirmesi. Makro Bakış Dergisi, 5. Kristensen F.B. (2008) Transnational Collaboration on Health Technology Assessment – A Political Priority in Europe. M.V. Garrido, F.B. Kristensen, C.P. Nielsen ve R. Busse (Ed.). Health Technology Assessment and Health Policy Making in Europe – Current Status, Challenges and Potential. Observatory Series No: 14. United Kingdom: WHO. Marshall D. Douglas P. Drummond M. Torrance G. MacLeod S. Manti O. Et al. (2008) Guidelines for Conducting Pharmaceutical Budget Impact Analysis for Submission to Public Drug Plans in Cana